SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-18-035525
Filing Date
2018-05-23
Accepted
2018-05-23 20:08:55
Documents
2
Period of Report
2018-05-23

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 10107
2 EX-24 ex-24.htm EX-24 11668
  Complete submission text file 0001104659-18-035525.txt   23143
Mailing Address C/O ALEXION PHARMACEUTICALS 352 KNOTTER DR CHESHIRE CT 06410
Business Address
BOESS CARSTEN (Reporting) CIK: 0001277495 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38492 | Film No.: 18856373

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Issuer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences